Furthermore, our study reveals that targeting NRF2 upregulates PHKG2, promoting ferroptosis, enhancing radiotherapy-induced mitochondrial stress-dependent iron toxicity, and increasing the sensitivity of NSCLC to radiotherapy. The gene discussed is NFE2L2; the disease is non-small cell lung carcinoma.